Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Inhye Ahn, M.D.

Concepts (141)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Lymphocytic, Chronic, B-Cell35202416446.500 Why?
Adenine1820249932.900 Why?
Piperidines18202416642.390 Why?
Pyrazoles12202120242.100 Why?
Pyrimidines13202330501.660 Why?
Protein Kinase Inhibitors14202357091.020 Why?
Vidarabine220243370.980 Why?
Antineoplastic Agents122024137080.900 Why?
Tumor Suppressor Protein p533202129640.790 Why?
Lymphoma, B-Cell220229450.620 Why?
Pneumocystis carinii12016720.510 Why?
Pneumonia, Pneumocystis120162420.480 Why?
Antineoplastic Combined Chemotherapy Protocols72023118430.460 Why?
Antibodies, Bispecific320232040.460 Why?
Philadelphia Chromosome120131190.420 Why?
Safety1201711590.420 Why?
Drug Resistance, Neoplasm6202453420.400 Why?
Irritable Bowel Syndrome120174540.400 Why?
Herpes Zoster Vaccine22022490.370 Why?
Integrin alpha4beta1220231190.360 Why?
Multiple Myeloma3201651920.330 Why?
Warfarin1201714930.320 Why?
Cyclophosphamide2202422240.290 Why?
Apoptosis1202495260.290 Why?
Myeloproliferative Disorders120136140.280 Why?
Benzamides3202113810.270 Why?
Phospholipase C gamma220171310.270 Why?
Pyrazines3202112060.270 Why?
Follow-Up Studies72024394300.230 Why?
Lymphoma2202319070.220 Why?
Renal Insufficiency, Chronic1201722910.220 Why?
Tumor Microenvironment2202339390.210 Why?
Disease-Free Survival3202068560.210 Why?
Aged, 80 and over102021596800.200 Why?
Humans4320247684510.190 Why?
Aged1820211715200.190 Why?
Vaccines, Synthetic220226220.190 Why?
Treatment Outcome102024654090.190 Why?
Molecular Targeted Therapy2202428340.180 Why?
Proto-Oncogene Proteins c-bcl-22202414090.170 Why?
Leukemia, Hairy Cell12020820.170 Why?
Hepatitis B Vaccines120211770.170 Why?
Hypertension1201986110.160 Why?
Herpes Zoster120222530.160 Why?
Lymphoma, Follicular120234600.160 Why?
Antigens, CD19220214370.160 Why?
Atrial Fibrillation1201751620.160 Why?
Smith-Magenis Syndrome12017190.150 Why?
Immunotherapy3202347280.150 Why?
Cell Transformation, Neoplastic2201828470.150 Why?
Protein-Tyrosine Kinases2201724340.140 Why?
Prognosis52023300280.140 Why?
Chromosomes, Human, Pair 17120174190.130 Why?
Disease Progression32020136550.130 Why?
Male1820213647810.130 Why?
Immunity1202110020.120 Why?
Sulfonamides1202419880.110 Why?
Mutation42023302430.110 Why?
Middle Aged1420212234180.110 Why?
Chromosome Deletion1201713900.100 Why?
Neoplasm, Residual1201810140.100 Why?
Switzerland220233220.100 Why?
Survival Rate32021128750.100 Why?
Hydroxyurea120132840.100 Why?
Thrombocythemia, Essential120131140.100 Why?
Antiviral Agents2202130630.100 Why?
Polycythemia Vera120131610.100 Why?
Female1420213969430.100 Why?
Transplantation, Autologous1201621260.090 Why?
Salvage Therapy1201812770.090 Why?
Histone-Lysine N-Methyltransferase120166970.090 Why?
Survival Analysis22020101250.090 Why?
Hodgkin Disease1201813860.090 Why?
Kaplan-Meier Estimate2201865370.090 Why?
Adult920212235420.090 Why?
Congresses as Topic220238100.080 Why?
Neoplasm Proteins1202036110.070 Why?
Receptors, Antigen, B-Cell220235450.070 Why?
Bone Marrow1201829290.070 Why?
CD8-Positive T-Lymphocytes1202146420.070 Why?
Quinazolines1201313760.070 Why?
Anemia1201615210.070 Why?
Clinical Trials as Topic1202180510.060 Why?
Repressor Proteins1201629870.060 Why?
Evidence-Based Medicine1201637080.060 Why?
High-Throughput Nucleotide Sequencing1201736650.060 Why?
Autoimmune Diseases1201622600.060 Why?
Neoplasm Staging12018112490.050 Why?
Comorbidity12017106010.050 Why?
Coronavirus Infections1202031160.050 Why?
Pneumonia, Viral1202032400.050 Why?
Cladribine12020340.040 Why?
Enzyme Induction120204550.040 Why?
Thrombosis1201329560.040 Why?
Hematopoietic Stem Cell Transplantation1201657090.040 Why?
Immunization, Passive120206210.040 Why?
Signal Transduction12021236380.040 Why?
Incidence12016215520.040 Why?
Single-Chain Antibodies120181120.040 Why?
RNA, Neoplasm120207510.040 Why?
Lymphocytosis120181210.030 Why?
Leukocytes, Mononuclear1202318550.030 Why?
Hematologic Diseases120204990.030 Why?
Immunity, Humoral120206130.030 Why?
Adjuvants, Immunologic120219980.030 Why?
Animals320231694180.030 Why?
Mice, Inbred NOD1201818390.030 Why?
Mice, SCID1201826330.030 Why?
Immunoglobulin M1201815290.030 Why?
Drug Administration Schedule1202048610.020 Why?
Headache1202012600.020 Why?
Drug Therapy, Combination1202163200.020 Why?
Cell Adhesion1201831030.020 Why?
Disease Management1202125330.020 Why?
Anti-Inflammatory Agents1202018160.020 Why?
Tumor Cells, Cultured1201861350.020 Why?
In Situ Hybridization, Fluorescence1201625250.020 Why?
Xenograft Model Antitumor Assays1201836190.020 Why?
Retrospective Studies22021818340.020 Why?
Vaccination1202134340.020 Why?
Phosphatidylinositol 3-Kinases1201828840.020 Why?
Epigenesis, Genetic1202138260.020 Why?
Polymerase Chain Reaction1201760910.020 Why?
Antibodies, Monoclonal1202392630.020 Why?
Biopsy1201868160.020 Why?
Lymph Nodes1201834720.020 Why?
Cells, Cultured12021190410.020 Why?
RNA, Messenger12020128130.020 Why?
Pain1202050960.020 Why?
Neoplasm Recurrence, Local1202394250.020 Why?
Multivariate Analysis12018120960.010 Why?
T-Lymphocytes12021102730.010 Why?
Combined Modality Therapy1201685590.010 Why?
Mice22023820450.010 Why?
DNA1201772130.010 Why?
Proportional Hazards Models12018125610.010 Why?
Sensitivity and Specificity12017147280.010 Why?
Pandemics1202087530.010 Why?
Gene Expression Profiling1201695070.010 Why?
United States12021731210.010 Why?
Young Adult12016600450.000 Why?
Ahn's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (141)
Explore
_
Co-Authors (27)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.